Literature DB >> 11691946

Hemolytic-uremic syndrome.

J J Corrigan, F G Boineau.   

Abstract

The hemolytic-uremic syndrome (HUS) has been recognized for more than 45 years and consists of the combination of hemolytic anemia, thrombocytopenia, and acute renal failure. HUS occurs predominantly in children younger than 4 years of age. It is the most frequent cause of acute renal failure in children. The most common form of the syndrome (D+ HUS) occurs in healthy young children (>6 mo to <5 y of age) and is preceded by watery diarrhea that can evolve to hemorrhagic colitis. The diarrhea precedes the hemolysis and thrombocytopenia by 5 to 7 days; oliguria/anuria follows several days later. Although the pathogenesis is unknown, available evidence strongly suggests that endothelial cell damage is necessary. The outcome for most patients who have D+ HUS is favorable: 65% to 85% recover completely, 5% to 10% die (usually during the acute illness), recurrence is uncommon, and only a few patients slowly progress to end-stage renal disease (ESRD).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11691946

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN: 0191-9601


  23 in total

1.  Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome.

Authors:  Philipp A Lang; Ortraud Beringer; Jan P Nicolay; Oliver Amon; Daniela S Kempe; Tobias Hermle; Philipp Attanasio; Ahmad Akel; Richard Schäfer; Björn Friedrich; Teut Risler; Matthias Baur; Christoph J Olbricht; Lothar Bernd Zimmerhackl; Peter F Zipfel; Thomas Wieder; Florian Lang
Journal:  J Mol Med (Berl)       Date:  2006-04-19       Impact factor: 4.599

2.  Evaluation of a real-time PCR kit for detecting Escherichia coli O157 in bovine fecal samples.

Authors:  James L Bono; James E Keen; Laura C Miller; James M Fox; Carol G Chitko-McKown; Michael P Heaton; William W Laegreid
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

Review 3.  Regulation of traffic and organelle architecture of the ER-Golgi interface by signal transduction.

Authors:  Kerstin D Tillmann; Valentina Millarte; Hesso Farhan
Journal:  Histochem Cell Biol       Date:  2013-07-03       Impact factor: 4.304

4.  Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function.

Authors:  Fadila Guessous; Marek Marcinkiewicz; Renata Polanowska-Grabowska; Sudawadee Kongkhum; Daniel Heatherly; Tom Obrig; Adrian R L Gear
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Induction of eryptosis by cyclosporine.

Authors:  Olivier M Niemoeller; Ahmad Akel; Philipp A Lang; Philipp Attanasio; Daniela S Kempe; Tobias Hermle; Malgorzata Sobiesiak; Thomas Wieder; Florian Lang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09-22       Impact factor: 3.000

6.  Case 6: An Infant Presenting with Hematuria and Pallor.

Authors:  Lauren C Riney; Jennifer D Treasure; Charles D Varnell; Holly Depinet
Journal:  Pediatr Rev       Date:  2018-02

7.  Hemolytic uremic syndrome associated with pneumococcal pneumonia in Taiwan.

Authors:  Yu-Hsuan Huang; Tzou-Yien Lin; Kin-Sun Wong; Yhu-Chering Huang; Cheng-Hsun Chiu; Shen-Hao Lai; Shao-Hsuan Hsia
Journal:  Eur J Pediatr       Date:  2006-02-24       Impact factor: 3.183

8.  First case report of Moraxella osloensis diarrhea in a hemolytic uremic syndrome/acute renal failure child from rural coastal India-Manipal, Karnataka.

Authors:  Mamatha Ballal; Suganthi Martena
Journal:  Indian J Pediatr       Date:  2012-01-10       Impact factor: 1.967

9.  Association of Escherichia coli O157:H7 tir polymorphisms with human infection.

Authors:  James L Bono; James E Keen; Michael L Clawson; Lisa M Durso; Michael P Heaton; William W Laegreid
Journal:  BMC Infect Dis       Date:  2007-08-24       Impact factor: 3.090

10.  Rapid conditional targeted ablation model for hemolytic anemia in the rat.

Authors:  Marina M Hanson; Fengming Liu; Shen Dai; Alison Kearns; Xuebin Qin; Elizabeth C Bryda
Journal:  Physiol Genomics       Date:  2016-07-01       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.